Entourage Lab

Entourage Lab is the first Brazilian company focused on the research and development of Cannabis-based medications. Founded in 2015, the company is a global pharmaceutical entity dedicated to the advancement and distribution of cannabis-based products and other natural compounds within the manufacturing and pharmaceutical industries. The company’s primary objective is to enhance health outcomes for patients of all ages. Entourage Lab aims to revolutionize healthcare by offering innovative solutions for the betterment of individuals worldwide. The core of their operations is centered around innovation. They have developed oral solutions carefully designed to harness an exclusive 'Entourage Effect', utilizing the synergistic potential of cannabis compounds to provide integrative treatment. Moreover, their formulations are optimized through Fusionner technology, ensuring enhanced accessibility, safety, and efficacy of their active ingredients. Entourage Lab extends an invitation for individuals interested in exploring the therapeutic potential of cannabis for health and wellness, or those looking to delve deeper into their products and research, to connect and participate in this transformative journey. As of now, Entourage Lab has not disclosed its last investment or the involved investors. However, with its pioneering position in the cannabis-based medication space and its commitment to innovation, the company presents an intriguing opportunity for potential investors in the pharmaceutical sector.